Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
DexCom
DXCM
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 25.73%8.69M | 12.96%1.97M | 6.44%1.8M | 8.20%1.88M | 75.15%3.03M | -33.08%6.91M | -53.66%1.75M | 38.49%1.69M | -13.43%1.74M | -47.94%1.73M |
Operating revenue | 25.73%8.69M | 12.96%1.97M | 6.44%1.8M | 8.20%1.88M | 75.15%3.03M | -33.08%6.91M | -53.66%1.75M | 38.49%1.69M | -13.43%1.74M | -47.94%1.73M |
Cost of revenue | -10.90%3.23M | 58.84%1.07M | -13.80%716.72K | -10.91%771.65K | -46.62%666.63K | -27.01%3.62M | -54.68%674.11K | 37.92%831.48K | 1.17%866.17K | -37.99%1.25M |
Gross profit | 66.05%5.46M | -15.85%903.07K | 25.95%1.09M | 27.15%1.11M | 391.53%2.36M | -38.68%3.29M | -52.99%1.07M | 39.03%862.39K | -24.28%872.96K | -63.25%480.62K |
Operating expense | -33.19%10.46M | 107.08%1.56M | -14.43%3.02M | -57.97%2.3M | -39.28%3.58M | -49.12%15.66M | -89.62%755.48K | -56.84%3.53M | -28.86%5.47M | -22.80%5.89M |
Selling and administrative expenses | -31.07%7.62M | -34.05%1.44M | 12.61%2.12M | -54.94%1.62M | -28.16%2.44M | -44.53%11.06M | -51.26%2.19M | -65.41%1.88M | -26.60%3.59M | -33.53%3.4M |
-Selling and marketing expense | -56.29%739.1K | -61.49%107.63K | -50.99%175.53K | -52.72%205.55K | -59.51%250.39K | -72.61%1.69M | -81.41%279.45K | -75.14%358.12K | -71.77%434.79K | -63.37%618.41K |
-General and administrative expense | -26.51%6.88M | -30.02%1.33M | 27.53%1.95M | -55.24%1.41M | -21.19%2.19M | -31.95%9.37M | -36.07%1.91M | -61.91%1.53M | -5.83%3.15M | -18.81%2.78M |
Research and development costs | -53.32%3.38M | -59.76%597.72K | -45.84%848.53K | -51.41%868.75K | -55.64%1.06M | -30.53%7.24M | -44.99%1.49M | -40.45%1.57M | -33.33%1.79M | -0.30%2.4M |
Depreciation amortization depletion | -47.67%208.65K | -79.62%24.64K | -37.64%47.15K | -39.78%63.14K | -24.27%73.72K | -5.10%398.7K | 29.09%120.88K | -18.43%75.61K | -10.93%104.85K | -16.13%97.35K |
-Depreciation and amortization | -47.67%208.65K | -79.62%24.64K | -37.64%47.15K | -39.78%63.14K | -24.27%73.72K | -5.10%398.7K | 29.09%120.88K | -18.43%75.61K | -10.93%104.85K | -16.13%97.35K |
Other operating expenses | 75.31%-750K | ---500K | ---- | -2,062.07%-250K | ---- | ---3.04M | ---- | ---- | ---11.56K | ---- |
Operating profit | 59.59%-5M | -308.16%-661.39K | 27.50%-1.93M | 74.13%-1.19M | 77.54%-1.22M | 51.33%-12.37M | 106.36%317.73K | 64.72%-2.66M | 29.67%-4.6M | 14.43%-5.41M |
Net non-operating interest income expense | 84.38%-120.76K | 69.40%-30.28K | 87.03%-29.85K | 87.85%-29.75K | 84.49%-30.88K | 32.68%-772.99K | 80.60%-98.93K | 6.03%-230.19K | -27.70%-244.75K | 1.23%-199.12K |
Non-operating interest expense | -84.38%120.76K | -69.40%30.28K | -87.03%29.85K | -87.85%29.75K | -84.49%30.88K | -32.68%772.99K | -80.60%98.93K | -6.03%230.19K | 27.70%244.75K | -1.23%199.12K |
Other net income (expense) | 275.02%2.07M | -189.20%-2.19M | 317.28%1.39M | 198.44%3.31M | -224.44%-437.19K | 88.49%-1.18M | 272.82%2.45M | 13.55%-639.15K | -342.18%-3.36M | 103.72%351.32K |
Special income (charges) | 181.11%3.25M | --0 | --0 | 181.11%3.25M | ---- | 58.36%-4M | --0 | --0 | -2,586.80%-4M | ---- |
-Less:Impairment of capital assets | --0 | --0 | --0 | --0 | ---- | -58.36%4M | --0 | --0 | 2,586.80%4M | ---- |
-Less:Other special charges | ---3.25M | --0 | ---- | ---3.25M | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -141.73%-1.18M | -189.20%-2.19M | 317.28%1.39M | -90.94%58.48K | -224.44%-437.19K | 523.76%2.82M | 189.82%2.45M | 13.55%-639.15K | 205.74%645.61K | 316.73%351.32K |
Income before tax | 78.72%-3.05M | -207.79%-2.88M | 83.79%-573.03K | 125.45%2.09M | 67.99%-1.68M | 61.12%-14.32M | 155.08%2.67M | 58.60%-3.53M | -9.53%-8.2M | 67.06%-5.26M |
Income tax | ||||||||||
Net income | 78.72%-3.05M | -207.79%-2.88M | 83.79%-573.03K | 125.45%2.09M | 67.99%-1.68M | 61.12%-14.32M | 155.08%2.67M | 58.60%-3.53M | -9.53%-8.2M | 67.06%-5.26M |
Net income continuous Operations | 78.72%-3.05M | -207.79%-2.88M | 83.79%-573.03K | 125.45%2.09M | 67.99%-1.68M | 61.12%-14.32M | 155.08%2.67M | 58.60%-3.53M | -9.53%-8.2M | 67.06%-5.26M |
Minority interest income | -295.12K | 1,091.57%975.27K | -2,084.18%-582.85K | -2,677.17%-288.82K | 69.26%-48.65K | 0 | -217.67%-98.36K | 237.07%29.38K | 113.60%11.21K | 80.92%-158.25K |
Net income attributable to the parent company | 80.78%-2.75M | -239.18%-3.85M | 100.28%9.83K | 128.94%2.38M | 67.95%-1.63M | 60.20%-14.32M | 156.14%2.77M | 58.15%-3.56M | -10.89%-8.21M | 66.30%-5.1M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 80.78%-2.75M | -239.18%-3.85M | 100.28%9.83K | 128.94%2.38M | 67.95%-1.63M | 60.20%-14.32M | 156.14%2.77M | 58.15%-3.56M | -10.89%-8.21M | 66.30%-5.1M |
Basic earnings per share | 83.09%-0.94 | -176.07%-0.89 | 100.25%0.0032 | 128.62%0.87 | 74.25%-0.6 | 81.91%-5.56 | 128.06%1.17 | 82.03%-1.31 | 52.05%-3.04 | 82.04%-2.33 |
Diluted earnings per share | 83.09%-0.94 | -176.07%-0.89 | 100.25%0.0032 | 128.62%0.87 | 74.25%-0.6 | 81.91%-5.56 | 128.06%1.17 | 82.03%-1.31 | 52.05%-3.04 | 82.04%-2.33 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |